Startups have raised billions of dollars in venture capital to develop software-based digital therapeutics for a range of diseases. Now, many are wrestling with the challenge of bringing these treatments to patients. Several are experimenting with new business strategies to clear hurdles to commercial success.
Click here for the full article.
